European Journal of Clinical Pharmacology, 77 (2), 251260
Semaglutide is the most commonly prescribed GLP-1 receptor agonist and is available under brand-name Ozempic (for T2D), Wegovy (for obesity), and Rybelsus (oral formulation for T2D)
The FDA-approved prescribing information for tirzepatide explicitly states that "there are no data on the presence of tirzepatide in human milk, the effects on the breastfed infant, or the effects on milk production." This absence of data reflects the exclusion of pregnant and breastfeeding individuals from clinical trials, a common practice that creates knowledge gaps for this population
If appendicitis is strongly suspected, a surgeon will often advise removing the appendix even if an ultrasound or CT scan cannot confirm the diagnosis
Megadoses of B12 can lead to headaches, nausea, diarrhea, vomiting, and flushing, he says
Are there any side effects from Semaglutide